Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 34, 2023 - Issue 1
Submit an article Journal homepage
1,994
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Paradoxical tralokinumab-induced psoriasis in a patient with atopic dermatitis

Galina Balakirskia Center for Dermatology, Allergology and Dermatosurgery, Helios University Hospital Wuppertal, University of Witten/Herdecke, Wuppertal, GermanyCorrespondence[email protected]
View further author information
,
Sven-Niklas Burmannb Department of Dermatology, Venereology and Allergology, Helios St. Elisabeth Hospital Oberhausen, University of Witten/Herdecke, Oberhausen, GermanyView further author information
,
Silke C. Hofmanna Center for Dermatology, Allergology and Dermatosurgery, Helios University Hospital Wuppertal, University of Witten/Herdecke, Wuppertal, GermanyView further author information
&
Alexander Kreuterb Department of Dermatology, Venereology and Allergology, Helios St. Elisabeth Hospital Oberhausen, University of Witten/Herdecke, Oberhausen, GermanyView further author information
Article: 2258240 | Received 17 Jul 2023, Accepted 08 Sep 2023, Published online: 13 Sep 2023

References

  • Guttman-Yassky E, Krueger JG. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr Opin Immunol. 2017;48:1–3. doi: 10.1016/j.coi.2017.08.008.
  • Barry K, Zancanaro P, Casseres R, et al. Concomitant atopic dermatitis and psoriasis - a retrospective review. J Dermatolog Treat. 2021;32(7):716–720. doi: 10.1080/09546634.2019.1702147.
  • Al-Janabi A, Foulkes AC, Mason K, et al. Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 2020;34(7):1440–1448. doi: 10.1111/jdv.16246.
  • Brumfiel CM, Patel MH, Zirwas MJ. Development of psoriasis during treatment with dupilumab: a systematic review. J Am Acad Dermatol. 2022;86(3):708–709. doi: 10.1016/j.jaad.2021.05.013.
  • Hahn M, Ghoreschi K. The role of IL-4 in psoriasis. Expert Rev Clin Immunol. 2017;13(3):171–173. doi: 10.1080/1744666X.2017.1279054.
  • Quattrini L, Caldarola G, Falco GM, et al. Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab-induced psoriasis. J Eur Acad Dermatol Venereol. 2023. doi: 10.1111/jdv.19351.
  • Mirza FN, Wang A, Ramachandran SM, et al. Dupilumab-induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin-17A expression: a case report. Br J Dermatol. 2021;185(2):432–434. doi: 10.1111/bjd.20064.
  • Colonna C, Bortoluzzi P, Cavalli R. Dupilumab treatment for severe atopic dermatitis in children and SARS-CoV-2 infection: a combination of triggers for psoriasis. J Eur Acad Dermatol Venereol. 2023;37(5):e568–e569. doi: 10.1111/jdv.18864.
  • Barry K, Zancanaro P, Casseres R, et al. A retrospective review of dupilumab and psoriasis biologic combination therapy. J Dermatolog Treat. 2021;32(4):438–439. doi: 10.1080/09546634.2019.1659481.
  • Tsai YC, Tsai TF. Overlapping features of psoriasis and atopic dermatitis: from genetics to immunopathogenesis to phenotypes. Int J Mol Sci. 2022;23(10):5518. doi: 10.3390/ijms23105518.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.